Edition:
United Kingdom

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

2.03USD
8:46pm BST
Change (% chg)

$0.07 (+3.57%)
Prev Close
$1.96
Open
$1.98
Day's High
$2.19
Day's Low
$1.97
Volume
18,084
Avg. Vol
65,835
52-wk High
$10.98
52-wk Low
$1.85

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -0.07
Market Cap(Mil.): $10.71
Shares Outstanding(Mil.): 4.70
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -5.38 -- --
ROI: -77.90 7.52 12.69
ROE: -85.31 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates